Stay updated on Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page adds a Locations section with Washington as a location and removes the HHS Vulnerability Disclosure entry. The page revision is updated to v3.3.3.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check49 days agoChange DetectedThe funding status notice has been removed from the page. The change does not affect the trial data, eligibility criteria, or how a user accesses the study details.SummaryDifference0.4%

- Check63 days agoChange DetectedThe changes appear to be visual/formatting updates to the study page, with no edits to core content such as the study purpose, eligibility criteria, endpoints, locations, or dates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check92 days agoChange DetectedMajor change: introduction of a government operating status notice and a version upgrade to v3.2.0; removal of the previous v3.1.0 tag indicates a new release.SummaryDifference3%

- Check99 days agoChange DetectedAdded revision label v3.1.0 and removed several topic blocks (Electromagnetic Radiation, Magnetic Phenomena, Electromagnetic Phenomena) along with the older revision tag v3.0.2.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page.